Konareva-Kostianeva Marieta
Department of Ophthalmology, Medical University-Plovdiv, Bulgaria.
Folia Med (Plovdiv). 2005;47(2):5-11.
Neovascular glaucoma is a severe eye disorder classified as a secondary glaucoma and the most common of this type of disease. It is caused by a number of ocular and systemic conditions, which share the common element of retinal ischemia/hypoxia that initiates the subsequent release of angiogenesis factors. The most common causes of neovascular glaucoma are diabetic retinopathy and the occlusion of central retinal vein, of carotid artery, and of central retinal artery. More rarely, neovascular glaucoma can be secondary to eye tumors, traumas and uveitis. The present article reviews the stages of angiogenesis, forms of neovascularization and the clinical stages of the disease. Differential diagnosis is made and modern treatment of neovascular glaucoma is reviewed: treatment of iris neovascularisation, of extensive neovascular glaucoma and of end-stage neovascular glaucoma. Being a disease with poor prognosis, neovascular glaucoma should be well known not only by ophthalmologists but also by general practitioners, endocrinologists, neurologists, rheumatologist, and cardiologists. Only a timely diagnosis and adequate treatment can assure patients that they will preserve their vision and/or eye for a longer time.
新生血管性青光眼是一种严重的眼部疾病,归类为继发性青光眼,也是此类疾病中最常见的一种。它由多种眼部和全身疾病引起,这些疾病都有视网膜缺血/缺氧这一共同因素,进而引发血管生成因子的后续释放。新生血管性青光眼最常见的病因是糖尿病视网膜病变以及视网膜中央静脉、颈动脉和视网膜中央动脉阻塞。较少见的情况下,新生血管性青光眼可继发于眼部肿瘤、外伤和葡萄膜炎。本文回顾了血管生成的阶段、新生血管形成的形式以及该疾病的临床阶段。进行了鉴别诊断,并综述了新生血管性青光眼的现代治疗方法:虹膜新生血管的治疗、广泛新生血管性青光眼的治疗和终末期新生血管性青光眼的治疗。作为一种预后不良的疾病,新生血管性青光眼不仅应该为眼科医生所熟知,也应该为全科医生、内分泌科医生、神经科医生、风湿科医生和心脏病科医生所熟知。只有及时诊断和适当治疗才能确保患者在更长时间内保持视力和/或保住眼睛。